GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Climb Bio CLYM · USD

Health Care · US listing · 🇺🇸 United States

Compare

11.01

+7.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Climb Bio and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Climb Bio CLYM 11.01$750.7m——— +7.00%
Lineage Cell Therapeutics LCTX 1.08$248.5m—-436.5%— +5.88%
Immix Biopharma IMMX 8.57$446.9m—9.2%— +6.33%
Absci ABSI 10.80$1.62bn—-4113.7%— +6.19%
QDM International QDMI 10.90$93.5m12.135.1%— +2.83%
Akebia Therapeutics AKBA 0.53$137.0m—-2.3%— +32.77%
Benitec Biopharma BNTC 9.87$357.4m—-24450.0%— +3.46%
SNDL SNDL 1.40$369.9m—-1.7%— -1.41%
Autolus Therapeutics AUTL 1.32$351.3m—-381.4%— +3.13%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.